BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Business

  Earnings Results, Dividend Authorizations, Conference Call Schedules, And Joint Ventures - Analyst Notes On Acadia Healthcare, HEALTHSOUTH, Air Methods, Brookdale And AMN Healthcare

  May 7, 2014

   · 

  1 min read
• Biotech Bay

  Arrowhead Research Corporation To Present At Upcoming Scientific Conferences

  May 7, 2014

   · 

  1 min read
• Business

  MEDA: Interim Report, January-March 2014

  May 7, 2014

   · 

  1 min read
• Business

  Concert Pharmaceuticals, Inc. To Report First Quarter 2014 Results On May 14, 2014

  May 7, 2014

   · 

  1 min read
• Biotech Bay

  Exelixis, Inc. To Present At Two Investor Conferences In May

  May 7, 2014

   · 

  1 min read
• Policy

  Janssen Research & Development Submits Supplemental New Drug Application To FDA For OLYSIO™ (Simeprevir) For Once-Daily Use In Combination With Sofosbuvir For 12 Weeks For The Treatment Of Adult Patients With Genotype 1 Chronic Hepatitis C

  May 7, 2014

   · 

  11 min read
• Protalix Biotherapeutics, Inc. To Present At The Oppenheimer 15th Annual Israeli Conference And The Mixiii Israel Innovation Conference, Biomed

  May 7, 2014

   · 

  1 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. CEO Named As Finalist For European Inventor Award

  May 7, 2014

   · 

  2 min read
• Biotech Beach

  Vital Therapies, Inc. (VTI) Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares

  May 7, 2014

   · 

  2 min read
• Policy

  Medivir AB Release: A Supplemental New Drug Application Has Been Submitted To The FDA For Simeprevir In Combination With Sofosbuvir

  May 7, 2014

   · 

  1 min read